Home |
Free Dividend Report |
Stock Splits Calendar |
EPZM Historical Stock Prices |
Preferred Stock Newsletter |
EPZM Options Chain |
Stock Message Boards |
EPZM (EPZM) has the following price history information. Looking back at EPZM historical stock prices for the last five trading days, on August 08, 2022, EPZM opened at $1.49, traded as high as $1.53 and as low as $1.47, and closed at $1.47. Trading volume was a total of 3.51M shares. On August 09, 2022, EPZM opened at $1.49, traded as high as $1.49 and as low as $1.47, and closed at $1.49. Trading volume was a total of 2.48M shares. On August 10, 2022, EPZM opened at $1.47, traded as high as $1.50 and as low as $1.47, and closed at $1.49. Trading volume was a total of 840.60K shares. On August 11, 2022, EPZM opened at $1.49, traded as high as $1.50 and as low as $1.47, and closed at $1.47. Trading volume was a total of 22.28M shares. On August 12, 2022, EPZM opened at $1.47, traded as high as $1.47 and as low as $1.47, and closed at $1.47. Trading volume was a total of 0 shares.
EPZM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into EPZM shares, starting with a $10,000 purchase of EPZM, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/29/2014 | |
End date: | 08/12/2022 | |
Start price/share: | $21.49 | |
End price/share: | $1.47 | |
Dividends collected/share: | $0.00 | |
Total return: | -93.16% | |
Average Annual Total Return: | -27.63% | |
Starting investment: | $10,000.00 | |
Ending investment: | $684.38 | |
Years: | 8.29 |
EPZM Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
08/08/2022 | $1.49 | $1.53 | $1.47 | $1.47 | 3.51M |
08/09/2022 | $1.49 | $1.49 | $1.47 | $1.49 | 2.48M |
08/10/2022 | $1.47 | $1.50 | $1.47 | $1.49 | 840.60K |
08/11/2022 | $1.49 | $1.50 | $1.47 | $1.47 | 22.28M |
08/12/2022 | $1.47 | $1.47 | $1.47 | $1.47 | 0 |
About EPZM |
Epizyme is a biopharmaceutical company that is focused on rewriting treatment for people with cancer and other serious diseases through the discovery, development, and commercialization of epigenetic medicines. Co. has one approved product, TAZVERIK (tazemetostat), which was granted approval by the U.S. Food and Drug Administration (FDA) for epithelioid sarcoma (ES), and follicular lymphoma (FL). The FDA has granted approval of TAZVERIK (tazemetostat), an oral, selective small molecule inhibitor of the EZH2 histone methyltransferase for the treatment of adult and pediatric patients aged 16 years and older with metastatic or locally advanced ES not eligible for complete resection. |
EPZM Historical Closing Prices | |
Date | Close |
08/08/2022 | $1.47 |
08/09/2022 | $1.49 |
08/10/2022 | $1.49 |
08/11/2022 | $1.47 |
08/12/2022 | $1.47 |
Healthcare Historical Prices |
EPZM is categorized under the Healthcare sector; below are some other companies in the same sector:
ERB Historical Stock Prices Also explore: EPZM shares outstanding history
Free EPZM Email Alerts:
|
EPZM Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.